Regional Versus General Anesthesia for Hip Fracture and Postoperative Oxygenation (REGENERATION)

December 19, 2025 updated by: ANDRE DOS SANTOS ROCHA, University of Lisbon

With this study, the investigators intend to measure oxygen saturation before and after hip surgery in the context of proximal femur fracture, comparing two types of anesthesia (general or spinal). The investigators also intend to study the effects of the two anesthetic techniques on sleep apnea, delirium, respiratory complications, and length of hospital stay.

This is an observational study, in which oxygen is measured at the fingertip with a sensor and a bracelet, without any intervention, inconvenience, or discomfort for the participant. Data will be collected on: respiratory complications, sleep apnea, delirium, length of hospital stay, and survival.

Data will be collected in the operating room and wards of Santa Maria Hospital, Lisbon, Portugal over a period of approximately 24 hours after the participant's operation. Information about participant's health and co-morbidities will be recorded.

There will be no implication for the participants' clinical care, since the study measurements will not be sent to the health professionals in charge. The operation, recovery, and treatments will not be influenced at any time by participation in the study.

Study Overview

Detailed Description

Frailty, comorbidities, medication (anticoagulants and anti-platellet agents) as well as acute and chronic illnesses have an impact on the choice of anesthesia strategy for hip fracture surgery. The choice between general anesthesia (GA) and loco-regional, spinal anesthesia (SA) may have impact on the postoperative period. Despite previous retrospective studies on this topic, it remains uncertain that either is superior in terms of post-operative outcomes, including mortality, delirium and respiratory complications, with conflicting results in the literature.

Postoperative pulmonary complications (PPC) are amongst the commonest complications in geriatric hip fractures, reported to be around 12%. The elder population at Hospital de Santa Maria (Tertiary University Hospital Center) receives the most challenging cases, with pilot data from the past 3 years (2022-2024, n=927) revealing an average risk score for PPC of 32,1%.

Considering that low oxygen saturation is an independent risk factor and a strong predictor for PPC, the investigators seek to compare the oxygenation during the perioperative period between the different anesthesia regimens.

The study hypothesis is that the anesthesia regimen (GA vs SA) has an impact on the oxygenation index during the first 24 postoperative hours.

The secondary objectives are to compare the sleep apnea index between GA and SA, the incidence of PPC, delirium, mortality and the length of stay (LOS) in the PACU and until discharge from the hospital.

Study Type

Observational

Enrollment (Estimated)

102

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lisbon District
      • Lisbon, Lisbon District, Portugal, 1635
        • Recruiting
        • Northern Lisbon Hospital Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Elder subjects with hip-fracture submitted to surgery.

Description

Inclusion Criteria:

  • hospital admission for hip fracture;
  • scheduled for hip fracture surgery;
  • age above 65 years, both genders;
  • capable of consent or consent by responsible person;

Exclusion Criteria:

  • hip fracture during hospitalization (not present upon admission)
  • patient refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
General anaesthesia
Hip fracture surgery under general anaesthesia
Rregional anaesthesia
Hip fracture surgery under regional anaesthesia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygenation index (SpO2/FiO2 ratio)
Time Frame: first postoperative day

Oxygenation index (SpO2/FiO2 ratio) measured as the difference between oxygenation index on admission to the operating room and the mean SpO2 during the next 24 postoperative hours, compared between groups.

Peripheral oxygen saturation measured continuously during the first postoperative day with the Konica Minolta PULSOX-DS5® device.

first postoperative day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep Apnea index
Time Frame: first postoperative day
average dips of SpO2 per hour, (>= 4%)
first postoperative day
Length of stay in the Post-anestesia Care Unit
Time Frame: after the surgery, at discharge from the Post-anestesia Care Unit
Length of stay in the Post-anestesia Care Unit
after the surgery, at discharge from the Post-anestesia Care Unit
Hospital Length of Stay (Days)
Time Frame: from hospital admission to hospital discharge, approximatelly 5 days
Length of stay in the hospital from admission until discharge, in days
from hospital admission to hospital discharge, approximatelly 5 days
postoperative pulmonary complications
Time Frame: during the first postoperative day
postoperative pulmonary complications defined as hypoxemia, respiratory failure, atelectasis, pneumothorax, respiratory infection.
during the first postoperative day
Delirium
Time Frame: during the first postoperative day
Presence of delirium in the first postoperative day
during the first postoperative day
in-Hospital mortality
Time Frame: From hospital admission to hospital discharge (or death), up to 3 months
death from any cause during hospital stay, from hospital admission to discharge
From hospital admission to hospital discharge (or death), up to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 27, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

November 27, 2025

First Submitted That Met QC Criteria

December 19, 2025

First Posted (Actual)

December 30, 2025

Study Record Updates

Last Update Posted (Actual)

December 30, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

only anonymised data can be shared after publication and upon reasonable request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on General Anaesthesia

Subscribe